Calgary, Alberta (Newsfile Corp. - September 20, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Terry Hébert
For Quebec’s faculties of medicine, which train future health professionals, revamping the health-care system must, above all, include training health-care personnel, promoting primary care and investing in teaching and research infrastructure.